Menu
Home
About Us
About Noxopharm
Board of Directors
Management Team
Our Science
About Veyonda
Publications
Pipeline & Clinical Programs
Investors
Share Price
ASX Announcements
Nox Insights
Media
Newsletters
Presentations & Interviews
Annual Reports
Financial Reports
Quarterly Reports
Analyst Reports
Corporate Governance
Company Constitution
Privacy Policy
Investor FAQs
Investors Glossary
Half Yearly Reports
Upcoming Events
EGM August 14, 2020
Contact Us/Partnering
Contact Us
Working at Noxopharm
Email Alerts
Partnering
NOX:
Market Cap:
Price Delay ~20min
Entitlement Offer Prospectus
May/June 2020
Investors
Home
>
Investors
>
Financial Reports
Share Price
ASX Announcements
Nox Insights
Media
Newsletters
Presentations & Interviews
Annual Reports
Financial Reports
Quarterly Reports
Analyst Reports
Corporate Governance
Company Constitution
Privacy Policy
Investor FAQs
Investors Glossary
Half Yearly Reports
Upcoming Events
EGM August 14, 2020
Financial Reports
Filter by Year:
2020
2019
2018
2017
2016
29-Jul-2020
Noxopharm 2020 June quarter Appendix 4C & Activities Report
30-Apr-2020
Noxopharm March 2020 Quarterly Report & Appendix 4C
25-Feb-2020
Half Year Accounts and Chairman Letter
31-Jan-2020
Appendix 4C - Quarterly Report for The Quarter Ending December 31, 2019
1
